Disclosure Of Income Tax [Text Block]

OSE Immunotherapeutics - Filing #5980970

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
Disclosure of income tax [text block]
Major components of tax expense (income) [abstract]
Tax expense (income)
2 387 EUR
219,000 EUR
Income tax relating to components of other comprehensive income [abstract]
Income tax relating to components of other comprehensive income
4,000 EUR
- EUR
Disclosure of temporary difference, unused tax losses and unused tax credits [text block]
Disclosure of temporary difference, unused tax losses and unused tax credits [abstract]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Deferred tax assets and liabilities [abstract]
Deferred tax assets
191,000 EUR
195,000 EUR
Deferred tax liabilities
1 074 EUR
1 311 EUR
Reconciliation of changes in deferred tax liability (asset) [abstract]
Changes in deferred tax liability (asset) [abstract]
Reconciliation of accounting profit multiplied by applicable tax rates [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.